Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Sarah-Jane Dawson
Based on 17 articles published since 2009
(Why 17 articles?)
||||
Expertise Level
The expertise of Sarah-Jane Dawson ranks in the
  • Top 0.26%
  • ... of 287,191 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 17 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Dawson, Sarah-Jane   ·   Dawson, S-J
Work Locations
Details
Most likely:    Peter MacCallum Cancer Centre      
2019
  • Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Electronic address: · Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium. · Department of Gynecology and Obstetrics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Clinical Laboratory, Hospital Arnau de Vilanova, Valencia, Spain. · Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece; Department of Medical Oncology, University Hospital of Heraklion, Greece. · Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy. · Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy. · DCIBERONC, IdISCC Madrid, Spain. · Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, UK. · Cancer Research UK Cambridge Institute and Department of Oncology Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. · Hospital 12 de Octubre, Madrid, Spain. · Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Hospital de Navarra, Pamplona, Spain. · Val d'Hebron Institute of Oncology, Val d'Hebron University Hospital, and Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Laboratory Medicine, Humanitas Reseach Hospital, Rozzano, Milan, Italy. · Women Cancer Center, Azienda Socio Sanitaria Territoriale di Cremona, University of Trieste, Italy. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia. · Frauenklinik, University of Ulm, Ulm, Germany. · Clinical Oncology, Hospital Arnau de Vilanova, Valencia, Spain. · Saarland University, Homburg, Germany. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Department of Medicine, University of Udine, Udine, UD, Italy. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, INSERM U1018, University Paris-Saclay, University Paris-Sud, Villejuif, France. · Department of Tumor Biology, Center of Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 30771872
2018
  • Andjelija Zivanovic Bujak and Sarah-Jane Dawson, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 29298118
2016
  • Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Victoria, Australia. · Cancer Genomics Program, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · kConFab, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · UCL Cancer Institute, CRUK Lung Cancer Centre of Excellence, London, United Kingdom. · The Francis Crick Institute, London, United Kingdom. · University of Applied Sciences Koblenz, RheinAhrCampus Remagen, Department of Mathematics and Technology, Remagen, Germany. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia. · Bioinformatics Division, Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Mathematics and Statistics, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28027312
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Montebello, Oslo 0310, Norway. · The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo 0318, Norway. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospitals NHS, Hills Road, Cambridge CB2 0QQ, UK. · Inivata, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Peter MacCallum Cancer Centre, Melbourne, Victoria 3002, Australia. · Illumina, Chesterford Research Park, Little Chesterford, Essex CB10 1XL, UK. · Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham NG5 1PB, UK. · Department of Pathology and Molecular Medicine, Queen's University/Kingston General Hospital, 76 Stuart Street, Kingston, Ontario, Canada K7L 2V7. · Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3. · Research Institute in Oncology and Hematology, 675 McDermot Avenue, Winnipeg, Mannitoba, Canada R3E 0V9. · NIHR Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and Research Oncology, Cancer Division, King's College London, London SE1 9RT, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts' Causeway, Cambridge CB1 8RN, UK. · Pubmed 27161491
  • Cancer Genomics Program, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · kConFab, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Oncology, the Royal Women's Hospital, Parkville, Victoria, Australia. · Department of Medicine, Dentistry and Health Sciences, the University of Melbourne, Parkville, Victoria, Australia. · Cancer Development and Treatment Laboratory, Research Department, Peter MacCallum Cancer, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia. · Department of Pain and Palliative Care, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Obstetrics and Gynaecology, the University of Melbourne, Parkville, Victoria, Australia. · Translational Breast Cancer Genomics and Therapeutics Laboratory, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia. · Tobin Brothers Funerals, Victoria, Australia. · Department of Pathology, the University of Melbourne, Parkville, Victoria, Australia. · Department of Physiology, Biomedicine Discovery Institute, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria, Australia. · Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria, Australia. · Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Molecular Genomics, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Bioinformatics and Cancer Genomics, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Department of Surgery, the University of Melbourne, Parkville, Victoria, Australia. · The Jack Brockhoff Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Hereditary Cancer Program, BC Cancer Agency, Vancouver, Canada. · Molecular Biomarkers and Translational Genomics Laboratory, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Nursing, the Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, the Royal Women's Hospital, Parkville, Victoria, Australia. · Department of Pathology, University of Dammam, Dammam, Saudi Arabia. · Department of Forensic Medicine, School of Public Health and Preventive Medicine, Monash University, Victoria, Australia. · The Garvan Institute, Sydney, New South Wales, Australia. · Pubmed 27617737
2015
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Oncology, University of Cambridge, Cambridge CB2 0RE, UK. · Center for Noninvasive Diagnostics, Translational Genomics Research Institute, Phoenix, Arizona 85004, USA. · Mayo Clinic Center for Individualized Medicine, Scottsdale, Arizona 85259, USA. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital National Health Service Foundation Trust and National Institute for Health Research Cambridge Biomedical Research Centre, and the Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0QQ, UK. · Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge CB2 0QQ, UK. · BC Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3. · Illumina, Inc., Chesterford Research Park, Little Chesterford CB10 1XL, UK. · Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Pubmed 26530965
2014
  • Department of Medical Oncology and Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Division of Cancer Medicine Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 25336116
Probable:    University of Melbourne      
2019
  • Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Electronic address: · Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium. · Department of Gynecology and Obstetrics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Clinical Laboratory, Hospital Arnau de Vilanova, Valencia, Spain. · Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece; Department of Medical Oncology, University Hospital of Heraklion, Greece. · Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy. · Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy. · DCIBERONC, IdISCC Madrid, Spain. · Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, UK. · Cancer Research UK Cambridge Institute and Department of Oncology Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. · Hospital 12 de Octubre, Madrid, Spain. · Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Hospital de Navarra, Pamplona, Spain. · Val d'Hebron Institute of Oncology, Val d'Hebron University Hospital, and Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Laboratory Medicine, Humanitas Reseach Hospital, Rozzano, Milan, Italy. · Women Cancer Center, Azienda Socio Sanitaria Territoriale di Cremona, University of Trieste, Italy. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia. · Frauenklinik, University of Ulm, Ulm, Germany. · Clinical Oncology, Hospital Arnau de Vilanova, Valencia, Spain. · Saarland University, Homburg, Germany. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Department of Medicine, University of Udine, Udine, UD, Italy. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, INSERM U1018, University Paris-Saclay, University Paris-Sud, Villejuif, France. · Department of Tumor Biology, Center of Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 30771872
2018
  • Andjelija Zivanovic Bujak and Sarah-Jane Dawson, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 29298118
2016
  • Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Victoria, Australia. · Cancer Genomics Program, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · kConFab, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · UCL Cancer Institute, CRUK Lung Cancer Centre of Excellence, London, United Kingdom. · The Francis Crick Institute, London, United Kingdom. · University of Applied Sciences Koblenz, RheinAhrCampus Remagen, Department of Mathematics and Technology, Remagen, Germany. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia. · Bioinformatics Division, Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Mathematics and Statistics, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28027312
  • Cancer Genomics Program, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · kConFab, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Oncology, the Royal Women's Hospital, Parkville, Victoria, Australia. · Department of Medicine, Dentistry and Health Sciences, the University of Melbourne, Parkville, Victoria, Australia. · Cancer Development and Treatment Laboratory, Research Department, Peter MacCallum Cancer, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia. · Department of Pain and Palliative Care, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Obstetrics and Gynaecology, the University of Melbourne, Parkville, Victoria, Australia. · Translational Breast Cancer Genomics and Therapeutics Laboratory, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia. · Tobin Brothers Funerals, Victoria, Australia. · Department of Pathology, the University of Melbourne, Parkville, Victoria, Australia. · Department of Physiology, Biomedicine Discovery Institute, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria, Australia. · Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria, Australia. · Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Molecular Genomics, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Bioinformatics and Cancer Genomics, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Department of Surgery, the University of Melbourne, Parkville, Victoria, Australia. · The Jack Brockhoff Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Hereditary Cancer Program, BC Cancer Agency, Vancouver, Canada. · Molecular Biomarkers and Translational Genomics Laboratory, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Nursing, the Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, the Royal Women's Hospital, Parkville, Victoria, Australia. · Department of Pathology, University of Dammam, Dammam, Saudi Arabia. · Department of Forensic Medicine, School of Public Health and Preventive Medicine, Monash University, Victoria, Australia. · The Garvan Institute, Sydney, New South Wales, Australia. · Pubmed 27617737
Probable:    University of Cambridge      
2018
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norway; Department of Pathology, Oslo University Hospital, Oslo, Norway. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Cancer Research UK Major Centre, Cambridge, United Kingdom. Electronic address: · Cambridge Breast Unit, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Cancer Research UK Major Centre, Cambridge, United Kingdom. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Cambridge Breast Unit, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom. · Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom. · UCL Genetics Institute, University College London, London, United Kingdom. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Cancer Research UK Major Centre, Cambridge, United Kingdom; Cambridge Breast Unit, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Cancer Research UK Major Centre, Cambridge, United Kingdom; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Cancer Research UK Major Centre, Cambridge, United Kingdom. Electronic address: · Pubmed 30165204
2016
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Montebello, Oslo 0310, Norway. · The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo 0318, Norway. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospitals NHS, Hills Road, Cambridge CB2 0QQ, UK. · Inivata, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Peter MacCallum Cancer Centre, Melbourne, Victoria 3002, Australia. · Illumina, Chesterford Research Park, Little Chesterford, Essex CB10 1XL, UK. · Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham NG5 1PB, UK. · Department of Pathology and Molecular Medicine, Queen's University/Kingston General Hospital, 76 Stuart Street, Kingston, Ontario, Canada K7L 2V7. · Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3. · Research Institute in Oncology and Hematology, 675 McDermot Avenue, Winnipeg, Mannitoba, Canada R3E 0V9. · NIHR Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and Research Oncology, Cancer Division, King's College London, London SE1 9RT, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts' Causeway, Cambridge CB1 8RN, UK. · Pubmed 27161491
2015
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Oncology, University of Cambridge, Cambridge CB2 0RE, UK. · Center for Noninvasive Diagnostics, Translational Genomics Research Institute, Phoenix, Arizona 85004, USA. · Mayo Clinic Center for Individualized Medicine, Scottsdale, Arizona 85259, USA. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital National Health Service Foundation Trust and National Institute for Health Research Cambridge Biomedical Research Centre, and the Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0QQ, UK. · Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge CB2 0QQ, UK. · BC Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3. · Illumina, Inc., Chesterford Research Park, Little Chesterford CB10 1XL, UK. · Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Pubmed 26530965
  • Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Pathology, University of Cambridge, Cambridge · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Edgbaston, Birmingham. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Strangeways Research Laboratory, University of Cambridge, Cambridge, UK. · Pubmed 25897014
2014
  • Cancer Research UK Cambridge Institute Departments of Pathology Oncology, University of Cambridge, Cambridge. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge Strangeways Research Laboratory, Cambridge. · Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Birmingham. · University of Leeds and Leeds Cancer Research UK Centre, St James' Institute of Oncology, Leeds, UK. · Ontario Institute for Cancer Research, Toronto, Canada and Biomarker and Companion Diagnostics, Edinburgh Cancer Research Centre, Edinburgh Department of Histopathology and School of Molecular Medical Sciences, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK. · Department of Pathology and Laboratory Medicine, University of British Columbia; Integrative Oncology Department, British Columbia Cancer Agency, Vancouver. · Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge · Pubmed 24915873
  • Department of Medical Oncology and SIRIC, Institut Curie, Paris, France; Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium. · Department of Gynecology and Obstetrics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Clinical Laboratory, Hospital Arnau de Vilanova, Valencia, Spain. · University Hospital of Heraklion, Heraklion, Greece. · Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy. · AZ Istituti Ospitalieri di Cremona, Cremona, Italy. · Department of Oncology, Hospital Clinico San Carlos, Department of Medicine, University Complutense of Madrid, Spain. · Imperial College and Imperial College Healthcare NHS Trust, London, UK. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, and NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. · Hospital 12 de Octubre, Madrid, Spain. · IOV-IRCCS, Padova, Italy. · Hospital de Navarra, Pamplona, Spain. · Val d'Hebron Institute of Oncology, Val d'Hebron University Hospital, and Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology and SIRIC, Institut Curie, Paris, France. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium; Department of Oncology, KU-Leuven, Leuven, Belgium. · Division of Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium. · Frauenklinik, University of Ulm, Ulm, Germany. · Clinical oncology, Hospital Arnau de Vilanova, Valencia, Spain. · Saarland University, Homburg, Germany. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Tumor Biology, Center of Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Medical Oncology and SIRIC, Institut Curie, Paris, France; Université Paris Descartes, Paris, France. Electronic address: · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Pubmed 24636208
2013
  • Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Pubmed 23395906
  • Department of Oncology, University of Cambridge and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, United Kingdom. · Pubmed 23484797
2013
  • Cancer Research UK Cambridge Institute and University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 23563269
  • Department of Oncology, University of Cambridge, Cambridge CB1 9RN, UK. · Pubmed 23329232
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 17 total) written by Sarah-Jane Dawson about Breast Neoplasms:

  • The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper. 2019
  • Circulating Tumor DNA Guides Prognosis in Metastatic Triple-Negative Breast Cancer. 2018
  • Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients. 2018
  • The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE". 2016
  • The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. 2016
  • A community-based model of rapid autopsy in end-stage cancer patients. 2016
  • Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer. 2015
  • PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes. 2015
  • Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality? 2014
  • Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients. 2014
Show List of Full Article Records
Google Searches

Learn more about Sarah-Jane Dawson using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Peter MacCallum Cancer Centre
University of Melbourne
University of Cambridge
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Peter MacCallum Cancer Centre
2019
  • Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Electronic address: · Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium. · Department of Gynecology and Obstetrics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Clinical Laboratory, Hospital Arnau de Vilanova, Valencia, Spain. · Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece; Department of Medical Oncology, University Hospital of Heraklion, Greece. · Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy. · Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy. · DCIBERONC, IdISCC Madrid, Spain. · Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, UK. · Cancer Research UK Cambridge Institute and Department of Oncology Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. · Hospital 12 de Octubre, Madrid, Spain. · Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Hospital de Navarra, Pamplona, Spain. · Val d'Hebron Institute of Oncology, Val d'Hebron University Hospital, and Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Laboratory Medicine, Humanitas Reseach Hospital, Rozzano, Milan, Italy. · Women Cancer Center, Azienda Socio Sanitaria Territoriale di Cremona, University of Trieste, Italy. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia. · Frauenklinik, University of Ulm, Ulm, Germany. · Clinical Oncology, Hospital Arnau de Vilanova, Valencia, Spain. · Saarland University, Homburg, Germany. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Department of Medicine, University of Udine, Udine, UD, Italy. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, INSERM U1018, University Paris-Saclay, University Paris-Sud, Villejuif, France. · Department of Tumor Biology, Center of Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 30771872
2018
  • Andjelija Zivanovic Bujak and Sarah-Jane Dawson, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 29298118
2016
  • Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Victoria, Australia. · Cancer Genomics Program, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · kConFab, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · UCL Cancer Institute, CRUK Lung Cancer Centre of Excellence, London, United Kingdom. · The Francis Crick Institute, London, United Kingdom. · University of Applied Sciences Koblenz, RheinAhrCampus Remagen, Department of Mathematics and Technology, Remagen, Germany. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia. · Bioinformatics Division, Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Mathematics and Statistics, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28027312
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Montebello, Oslo 0310, Norway. · The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo 0318, Norway. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospitals NHS, Hills Road, Cambridge CB2 0QQ, UK. · Inivata, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Peter MacCallum Cancer Centre, Melbourne, Victoria 3002, Australia. · Illumina, Chesterford Research Park, Little Chesterford, Essex CB10 1XL, UK. · Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham NG5 1PB, UK. · Department of Pathology and Molecular Medicine, Queen's University/Kingston General Hospital, 76 Stuart Street, Kingston, Ontario, Canada K7L 2V7. · Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3. · Research Institute in Oncology and Hematology, 675 McDermot Avenue, Winnipeg, Mannitoba, Canada R3E 0V9. · NIHR Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and Research Oncology, Cancer Division, King's College London, London SE1 9RT, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts' Causeway, Cambridge CB1 8RN, UK. · Pubmed 27161491
  • Cancer Genomics Program, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · kConFab, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Oncology, the Royal Women's Hospital, Parkville, Victoria, Australia. · Department of Medicine, Dentistry and Health Sciences, the University of Melbourne, Parkville, Victoria, Australia. · Cancer Development and Treatment Laboratory, Research Department, Peter MacCallum Cancer, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia. · Department of Pain and Palliative Care, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Obstetrics and Gynaecology, the University of Melbourne, Parkville, Victoria, Australia. · Translational Breast Cancer Genomics and Therapeutics Laboratory, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia. · Tobin Brothers Funerals, Victoria, Australia. · Department of Pathology, the University of Melbourne, Parkville, Victoria, Australia. · Department of Physiology, Biomedicine Discovery Institute, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria, Australia. · Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria, Australia. · Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Molecular Genomics, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Bioinformatics and Cancer Genomics, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Department of Surgery, the University of Melbourne, Parkville, Victoria, Australia. · The Jack Brockhoff Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Hereditary Cancer Program, BC Cancer Agency, Vancouver, Canada. · Molecular Biomarkers and Translational Genomics Laboratory, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Nursing, the Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, the Royal Women's Hospital, Parkville, Victoria, Australia. · Department of Pathology, University of Dammam, Dammam, Saudi Arabia. · Department of Forensic Medicine, School of Public Health and Preventive Medicine, Monash University, Victoria, Australia. · The Garvan Institute, Sydney, New South Wales, Australia. · Pubmed 27617737
2015
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Oncology, University of Cambridge, Cambridge CB2 0RE, UK. · Center for Noninvasive Diagnostics, Translational Genomics Research Institute, Phoenix, Arizona 85004, USA. · Mayo Clinic Center for Individualized Medicine, Scottsdale, Arizona 85259, USA. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital National Health Service Foundation Trust and National Institute for Health Research Cambridge Biomedical Research Centre, and the Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0QQ, UK. · Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge CB2 0QQ, UK. · BC Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3. · Illumina, Inc., Chesterford Research Park, Little Chesterford CB10 1XL, UK. · Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Pubmed 26530965
2014
  • Department of Medical Oncology and Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Division of Cancer Medicine Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 25336116
University of Melbourne
2019
  • Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Electronic address: · Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium. · Department of Gynecology and Obstetrics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Clinical Laboratory, Hospital Arnau de Vilanova, Valencia, Spain. · Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece; Department of Medical Oncology, University Hospital of Heraklion, Greece. · Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy. · Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy. · DCIBERONC, IdISCC Madrid, Spain. · Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, UK. · Cancer Research UK Cambridge Institute and Department of Oncology Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. · Hospital 12 de Octubre, Madrid, Spain. · Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Hospital de Navarra, Pamplona, Spain. · Val d'Hebron Institute of Oncology, Val d'Hebron University Hospital, and Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Laboratory Medicine, Humanitas Reseach Hospital, Rozzano, Milan, Italy. · Women Cancer Center, Azienda Socio Sanitaria Territoriale di Cremona, University of Trieste, Italy. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia. · Frauenklinik, University of Ulm, Ulm, Germany. · Clinical Oncology, Hospital Arnau de Vilanova, Valencia, Spain. · Saarland University, Homburg, Germany. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Department of Medicine, University of Udine, Udine, UD, Italy. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, INSERM U1018, University Paris-Saclay, University Paris-Sud, Villejuif, France. · Department of Tumor Biology, Center of Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 30771872
2018
  • Andjelija Zivanovic Bujak and Sarah-Jane Dawson, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 29298118
2016
  • Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Victoria, Australia. · Cancer Genomics Program, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · kConFab, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · UCL Cancer Institute, CRUK Lung Cancer Centre of Excellence, London, United Kingdom. · The Francis Crick Institute, London, United Kingdom. · University of Applied Sciences Koblenz, RheinAhrCampus Remagen, Department of Mathematics and Technology, Remagen, Germany. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia. · Bioinformatics Division, Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Mathematics and Statistics, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28027312
  • Cancer Genomics Program, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · kConFab, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Oncology, the Royal Women's Hospital, Parkville, Victoria, Australia. · Department of Medicine, Dentistry and Health Sciences, the University of Melbourne, Parkville, Victoria, Australia. · Cancer Development and Treatment Laboratory, Research Department, Peter MacCallum Cancer, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia. · Department of Pain and Palliative Care, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Obstetrics and Gynaecology, the University of Melbourne, Parkville, Victoria, Australia. · Translational Breast Cancer Genomics and Therapeutics Laboratory, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia. · Tobin Brothers Funerals, Victoria, Australia. · Department of Pathology, the University of Melbourne, Parkville, Victoria, Australia. · Department of Physiology, Biomedicine Discovery Institute, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria, Australia. · Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria, Australia. · Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Molecular Genomics, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Bioinformatics and Cancer Genomics, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Department of Surgery, the University of Melbourne, Parkville, Victoria, Australia. · The Jack Brockhoff Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Hereditary Cancer Program, BC Cancer Agency, Vancouver, Canada. · Molecular Biomarkers and Translational Genomics Laboratory, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Nursing, the Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, the Royal Women's Hospital, Parkville, Victoria, Australia. · Department of Pathology, University of Dammam, Dammam, Saudi Arabia. · Department of Forensic Medicine, School of Public Health and Preventive Medicine, Monash University, Victoria, Australia. · The Garvan Institute, Sydney, New South Wales, Australia. · Pubmed 27617737
University of Cambridge
2018
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norway; Department of Pathology, Oslo University Hospital, Oslo, Norway. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Cancer Research UK Major Centre, Cambridge, United Kingdom. Electronic address: · Cambridge Breast Unit, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Cancer Research UK Major Centre, Cambridge, United Kingdom. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Cambridge Breast Unit, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom. · Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom. · UCL Genetics Institute, University College London, London, United Kingdom. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Cancer Research UK Major Centre, Cambridge, United Kingdom; Cambridge Breast Unit, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Cancer Research UK Major Centre, Cambridge, United Kingdom; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Cancer Research UK Major Centre, Cambridge, United Kingdom. Electronic address: · Pubmed 30165204
2016
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Montebello, Oslo 0310, Norway. · The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo 0318, Norway. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospitals NHS, Hills Road, Cambridge CB2 0QQ, UK. · Inivata, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Peter MacCallum Cancer Centre, Melbourne, Victoria 3002, Australia. · Illumina, Chesterford Research Park, Little Chesterford, Essex CB10 1XL, UK. · Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham NG5 1PB, UK. · Department of Pathology and Molecular Medicine, Queen's University/Kingston General Hospital, 76 Stuart Street, Kingston, Ontario, Canada K7L 2V7. · Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3. · Research Institute in Oncology and Hematology, 675 McDermot Avenue, Winnipeg, Mannitoba, Canada R3E 0V9. · NIHR Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and Research Oncology, Cancer Division, King's College London, London SE1 9RT, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts' Causeway, Cambridge CB1 8RN, UK. · Pubmed 27161491
2015
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Oncology, University of Cambridge, Cambridge CB2 0RE, UK. · Center for Noninvasive Diagnostics, Translational Genomics Research Institute, Phoenix, Arizona 85004, USA. · Mayo Clinic Center for Individualized Medicine, Scottsdale, Arizona 85259, USA. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital National Health Service Foundation Trust and National Institute for Health Research Cambridge Biomedical Research Centre, and the Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0QQ, UK. · Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge CB2 0QQ, UK. · BC Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3. · Illumina, Inc., Chesterford Research Park, Little Chesterford CB10 1XL, UK. · Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Pubmed 26530965
  • Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Pathology, University of Cambridge, Cambridge · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Edgbaston, Birmingham. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Strangeways Research Laboratory, University of Cambridge, Cambridge, UK. · Pubmed 25897014
2014
  • Cancer Research UK Cambridge Institute Departments of Pathology Oncology, University of Cambridge, Cambridge. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge Strangeways Research Laboratory, Cambridge. · Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Birmingham. · University of Leeds and Leeds Cancer Research UK Centre, St James' Institute of Oncology, Leeds, UK. · Ontario Institute for Cancer Research, Toronto, Canada and Biomarker and Companion Diagnostics, Edinburgh Cancer Research Centre, Edinburgh Department of Histopathology and School of Molecular Medical Sciences, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK. · Department of Pathology and Laboratory Medicine, University of British Columbia; Integrative Oncology Department, British Columbia Cancer Agency, Vancouver. · Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge · Pubmed 24915873
  • Department of Medical Oncology and SIRIC, Institut Curie, Paris, France; Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium. · Department of Gynecology and Obstetrics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Clinical Laboratory, Hospital Arnau de Vilanova, Valencia, Spain. · University Hospital of Heraklion, Heraklion, Greece. · Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy. · AZ Istituti Ospitalieri di Cremona, Cremona, Italy. · Department of Oncology, Hospital Clinico San Carlos, Department of Medicine, University Complutense of Madrid, Spain. · Imperial College and Imperial College Healthcare NHS Trust, London, UK. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, and NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. · Hospital 12 de Octubre, Madrid, Spain. · IOV-IRCCS, Padova, Italy. · Hospital de Navarra, Pamplona, Spain. · Val d'Hebron Institute of Oncology, Val d'Hebron University Hospital, and Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology and SIRIC, Institut Curie, Paris, France. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium; Department of Oncology, KU-Leuven, Leuven, Belgium. · Division of Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium. · Frauenklinik, University of Ulm, Ulm, Germany. · Clinical oncology, Hospital Arnau de Vilanova, Valencia, Spain. · Saarland University, Homburg, Germany. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Tumor Biology, Center of Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Medical Oncology and SIRIC, Institut Curie, Paris, France; Université Paris Descartes, Paris, France. Electronic address: · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Pubmed 24636208
2013
  • Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Pubmed 23395906
  • Department of Oncology, University of Cambridge and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, United Kingdom. · Pubmed 23484797
2013
  • Cancer Research UK Cambridge Institute and University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 23563269
  • Department of Oncology, University of Cambridge, Cambridge CB1 9RN, UK. · Pubmed 23329232
University of London
2018
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norway; Department of Pathology, Oslo University Hospital, Oslo, Norway. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Cancer Research UK Major Centre, Cambridge, United Kingdom. Electronic address: · Cambridge Breast Unit, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Cancer Research UK Major Centre, Cambridge, United Kingdom. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Cambridge Breast Unit, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom. · Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom. · UCL Genetics Institute, University College London, London, United Kingdom. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Cancer Research UK Major Centre, Cambridge, United Kingdom; Cambridge Breast Unit, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Cancer Research UK Major Centre, Cambridge, United Kingdom; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Cancer Research UK Major Centre, Cambridge, United Kingdom. Electronic address: · Pubmed 30165204
2016
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Montebello, Oslo 0310, Norway. · The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo 0318, Norway. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospitals NHS, Hills Road, Cambridge CB2 0QQ, UK. · Inivata, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Peter MacCallum Cancer Centre, Melbourne, Victoria 3002, Australia. · Illumina, Chesterford Research Park, Little Chesterford, Essex CB10 1XL, UK. · Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham NG5 1PB, UK. · Department of Pathology and Molecular Medicine, Queen's University/Kingston General Hospital, 76 Stuart Street, Kingston, Ontario, Canada K7L 2V7. · Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3. · Research Institute in Oncology and Hematology, 675 McDermot Avenue, Winnipeg, Mannitoba, Canada R3E 0V9. · NIHR Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and Research Oncology, Cancer Division, King's College London, London SE1 9RT, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts' Causeway, Cambridge CB1 8RN, UK. · Pubmed 27161491
2015
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Oncology, University of Cambridge, Cambridge CB2 0RE, UK. · Center for Noninvasive Diagnostics, Translational Genomics Research Institute, Phoenix, Arizona 85004, USA. · Mayo Clinic Center for Individualized Medicine, Scottsdale, Arizona 85259, USA. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital National Health Service Foundation Trust and National Institute for Health Research Cambridge Biomedical Research Centre, and the Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0QQ, UK. · Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge CB2 0QQ, UK. · BC Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3. · Illumina, Inc., Chesterford Research Park, Little Chesterford CB10 1XL, UK. · Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Pubmed 26530965
  • Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Pathology, University of Cambridge, Cambridge · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Edgbaston, Birmingham. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Strangeways Research Laboratory, University of Cambridge, Cambridge, UK. · Pubmed 25897014
2014
  • Cancer Research UK Cambridge Institute Departments of Pathology Oncology, University of Cambridge, Cambridge. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge Strangeways Research Laboratory, Cambridge. · Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Birmingham. · University of Leeds and Leeds Cancer Research UK Centre, St James' Institute of Oncology, Leeds, UK. · Ontario Institute for Cancer Research, Toronto, Canada and Biomarker and Companion Diagnostics, Edinburgh Cancer Research Centre, Edinburgh Department of Histopathology and School of Molecular Medical Sciences, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK. · Department of Pathology and Laboratory Medicine, University of British Columbia; Integrative Oncology Department, British Columbia Cancer Agency, Vancouver. · Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge · Pubmed 24915873
  • Department of Medical Oncology and SIRIC, Institut Curie, Paris, France; Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium. · Department of Gynecology and Obstetrics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Clinical Laboratory, Hospital Arnau de Vilanova, Valencia, Spain. · University Hospital of Heraklion, Heraklion, Greece. · Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy. · AZ Istituti Ospitalieri di Cremona, Cremona, Italy. · Department of Oncology, Hospital Clinico San Carlos, Department of Medicine, University Complutense of Madrid, Spain. · Imperial College and Imperial College Healthcare NHS Trust, London, UK. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, and NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. · Hospital 12 de Octubre, Madrid, Spain. · IOV-IRCCS, Padova, Italy. · Hospital de Navarra, Pamplona, Spain. · Val d'Hebron Institute of Oncology, Val d'Hebron University Hospital, and Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology and SIRIC, Institut Curie, Paris, France. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium; Department of Oncology, KU-Leuven, Leuven, Belgium. · Division of Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium. · Frauenklinik, University of Ulm, Ulm, Germany. · Clinical oncology, Hospital Arnau de Vilanova, Valencia, Spain. · Saarland University, Homburg, Germany. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Tumor Biology, Center of Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Medical Oncology and SIRIC, Institut Curie, Paris, France; Université Paris Descartes, Paris, France. Electronic address: · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Pubmed 24636208
2013
  • Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Pubmed 23395906
  • Department of Oncology, University of Cambridge and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, United Kingdom. · Pubmed 23484797
2013
  • Cancer Research UK Cambridge Institute and University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 23563269
National Institutes of Health
2014
  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA, · Pubmed 24292867
Yearly article counts 12032450000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.